Pfizer Faces Celebrex Fallout
Pfizer is dealing with repercussions of a study linking its painkiller Celebrex to an increased risk of heart trouble. The company will stop airing its ads for the drug in response to a request from the Food and Drug Administration, which is mulling further action. Meanwhile, Pfizer's stock continued to sink on Wall Street. NPR's Snigdha Prakash reports.
Copyright 2004 NPR